Hints and tips:
...Lentz joins from Thompson & Knight. Latham & Watkins has hired Meghan Cocci as a partner in the law firm’s corporate department....
...Thompson, a Briton who also chairs UK private equity group 3i, will take up the position in March, when Jan du Plessis steps down....
...star Regulatory oversight has not kept up with growth in premiums Indian banks: power to the consumer Private-sector lenders exposed to the consumer sector should outperform European takeovers: Macron v...
...The German company shares its name and historical ties with Merck & Co of the US, but the pair are now separate companies, with Merck KGaA of Germany holding global rights to the name while the US drugmaker...
...The rebuffing of the bid made life harder for Aerojet, Mr Thompson added....
...“We are going to create medicines that measure,” says chief executive Andrew Thompson....
...ULA has stockpiled two years’ worth of RD180s for launches – and could switch more launches from the Atlas V to its more old-fashioned but wholly US-sourced Delta rockets....
...Top shareholdings: Resolute Forest Products; Dex Media; Cooper Tire & Rubber Company; IBM; Merck & Co; New York Times. Portfolio Value: $2.5bn....
...Earnings Apple Q4 $7.89 ($8.67) Burger King Q3 $0.21 ($0.17) Ferrovial Q3 NA (€0.20) Merck Q3 $0.88 ($0.95) Wolfson Microelectronics anticipates third-quarter results to be around $44m, after the...
...CA Inc climbed 9.6 per cent to $25.02 as the software developer easily beat analyst expectations....
...She joins GSK with Judy Lewent, former finance director of Merck. Their appointments by GSK chairman Sir Chris Gent takes the female quotient of the 15-member board to three....
...“There is very substantial under-reporting of adverse drug reactions,” says John Thompson, a pharmacologist at Cardiff University....
...Dorothy Thompson Chief executive of Drax, the power generator, since 2005. Previously head of the European business of InterGen, the power generation subsidiary of Shell and Bechtel....
...Bad news for leading drug makers Merck and Schering-Plough undercut positive sentiment Monday....
...Wyeth, Merck and other drugmakers face thousands of such suits potentially worth billions of dollars. The issue in the case is whether state law claims are pre-empted under federal law....
...But Merck’s superior gross margins and the strength of its near-term drug pipeline won this round....
...Manufacturer victories would be good news for an industry smarting from the Vioxx withdrawal, which cost Merck more than $6bn in legal and settlement costs....
...Even as a member of the minority, Mr Waxman was already a thorn in the side of branded drug groups such as Merck....
...He was born in 1954, the year, as he points out, of the famous Brown v Board of Education case which paved the way for US desegregation....
...Shares in Germany's Merck, the pharmaceuticals and chemicals group, sprinted towards the top of Frankfurt's midcap index, advancing 4.3 per cent at €55.75 after Deutsche Bank upgraded the stock to “buy”...
...The leap in profits included a one-off fee of DKr421m from a licensing deal with Merck of the US for the rights to Lundbeck's Gaboxadol sleeping disorder drug....
...But news of a confidence-shattering drug withdrawal by Merck, the US pharmaceuticals giant, which saw Merck shares plummet, unleashed a flurry of selling on Wall Street....
International Edition